Skip to main content

Xatmep News

Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis

TUESDAY, May 20, 2025 – For patients with pulmonary sarcoidosis, methotrexate is noninferior to prednisone with regard to the change from baseline to week 24 in the percentage of the predicted...

Glucarpidase Improves Outcomes in Patients With Methotrexate-Induced Kidney Toxicity

THURSDAY, Jan. 16, 2025 – For patients with methotrexate (MTX)-acute kidney injury (AKI), glucarpidase is associated with improved renal and extrarenal outcomes, according to a study published...

FDA Approves Xatmep (methotrexate) Oral Solution

Denver, April 26, 2017 — Silvergate Pharmaceuticals, Inc. leaders in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food a...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Acute Lymphoblastic Leukemia

Xatmep patient information at Drugs.com